openPR Logo
Press release

Strong Growth Ahead: Generic Musculoskeletal Disorders Drugs Market Size To Grow At Arecord 7.2% Cagr By 2029

05-29-2025 08:25 AM CET | Health & Medicine

Press release from: The Business Research Company

Generic Musculoskeletal Disorders Drugs

Generic Musculoskeletal Disorders Drugs

The Generic Musculoskeletal Disorders Drugs Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Projected Growth of the Generic Musculoskeletal Disorders Drugs Market?
The market size of generic drugs for musculoskeletal disorders has seen robust growth lately. It is expected to rise from $0.06 billion in 2024 to $0.06 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 6.7%. Factors such as the prevalence of musculoskeletal disorders, regulatory landscape, improvement in healthcare infrastructure, patient awareness & education, and economic conditions contributed to the historical growth.

The market size of generic drugs for musculoskeletal disorders is forecasted to experience considerable growth in the coming years, anticipated to reach a value of $0.08 billion by 2029, growing at a compound annual growth rate (CAGR) of 7.2%. This anticipated growth during the forecast period is attributed to factors such as a growing and aging population, emerging markets, advancements in personalized and precision medicines, healthcare reforms, and global health movements. Key trends expected during this forecast period involve the incorporation of technology in treatment procedures, initiatives and policies implemented by governments and healthcare entities, a shift in focus towards alternatives for pain management, a rise in the adoption of biosimilars, and advancements in the development of generic drugs.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9433

What Are the Emerging Segments Within the Generic Musculoskeletal Disorders Drugs Market?
The generic musculoskeletal disorders drugs market covered in this report is segmented -

1) By Treatment Type: Medication, Therapy, Surgery, Other Treatment Types
2) By Disorder Type: Osteoarthritis, Rheumatoid Arthritis, Spondylarthritis, Juvenile Idiopathic Arthritis, Psoriatic Arthritis, Fibromyalgia, Other Disorder Types
3) By Route Of Administration: Oral, Parenteral, Other Routes
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Drug Store, Online Pharmacy

Subsegments:
1) By Medication: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Analgesics, Corticosteroids, Disease-Modifying Antirheumatic Drugs (DMARDs), Biologics
2) By Therapy: Physical Therapy, Occupational Therapy, Chiropractic Treatment, Massage Therapy
3) By Surgery: Joint Replacement Surgery, Arthroscopy, Spinal Surgery, Fusion Surgery
4) By Other Treatment Types: Lifestyle Modifications, Alternative Therapies, Assistive Devices

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9433&type=smp

What Long-Term Drivers Are Shaping Generic Musculoskeletal Disorders Drugs Market Trends?
The considerable rate of arthritis is anticipated to spur the expansion of the generic musculoskeletal disorders drugs market in the future. Arthritis denotes the inflammation and swelling of joints accompanied by symptoms such as joint pain and rigidity. These generic drugs for musculoskeletal disorders aid in alleviating pain and muscle stiffness, and can also treat muscle spasms in individuals with arthritis. For instance, based on information released by Versus Arthritis, a charity in the UK, in March 2022, approximately 10 million people in the UK were diagnosed with osteoarthritis, which includes 5.4 million with knee OA and 3.2 million with hip OA. Additionally, roughly 450,000 have rheumatoid arthritis and 190,000 have psoriatic arthritis. This all adds up to more than 20 million people living with musculoskeletal conditions, leading to over 30 million prescriptions for these ailments at a cost of approximately £139 million in 2022-2023. For this reason, the significant occurrence of arthritis is pushing the growth of the generic musculoskeletal disorders drugs market.

Who Are the Top Competitors in Key Generic Musculoskeletal Disorders Drugs Market Segments?
Major companies operating in the generic musculoskeletal disorders drugs market include Pfizer Inc., Sanofi S.A., Eli Lilly and Company, Ampio Pharmaceuticals Inc., Amgen Inc., Boehringer Ingelheim International GmbH, Merck & Co. Inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceuticals Industries Ltd., AstraZeneca plc, Mitsubishi Tanabe Pharma Corporation, Horizon Therapeutics plc, Eisai Co. Ltd., Biogen Inc., Sino Biopharmaceutical Limited, Bristol-Myers Squibb Company, Johnson & Johnson Services Inc., AbbVie Inc., Novartis AG, F. Hoffmann-La Roche Ltd., Bayer AG, Mylan Pharmaceuticals Inc., Taisho Pharmaceutical Holdings Co. Ltd., Flexion Therapeutics Inc.

What Generic Musculoskeletal Disorders Drugs Market Trends Are Gaining Traction Across Different Segments?
The trend of strategic alliances is increasingly becoming significant in the generic musculoskeletal disorders drugs market. A multitude of companies within the business are forming collaborations to reinforce their market standing. To illustrate, a collaboration was formed in July 2022, between Japan-based Mitsubishi Tanabe Pharma Corporation and the United States' Eli Lilly and Company. This joint initiative facilitates expansion of their product offerings, providing effective solutions for diseases, including diabetes, among others. Moreover, in February 2022, Pfizer Inc., an American pharmaceutical and biotech firm, entered into a partnership with Alex Therapeutics, a digital therapeutics firm based in Sweden. This innovative strategic partnership delivers patients accredited, evidence-based, and personalized digital therapeutics.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/generic-musculoskeletal-disorders-drugs-global-market-report

Which Regions Are Becoming Hubs for Generic Musculoskeletal Disorders Drugs Market Innovation?
Asia-Pacific was the largest region in the generic musculoskeletal disorders drugs market in 2024. The regions covered in the generic musculoskeletal disorders drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Generic Musculoskeletal Disorders Drugs Market?
2. What is the CAGR expected in the Generic Musculoskeletal Disorders Drugs Market?
3. What Are the Key Innovations Transforming the Generic Musculoskeletal Disorders Drugs Industry?
4. Which Region Is Leading the Generic Musculoskeletal Disorders Drugs Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Strong Growth Ahead: Generic Musculoskeletal Disorders Drugs Market Size To Grow At Arecord 7.2% Cagr By 2029 here

News-ID: 4041802 • Views:

More Releases from The Business Research Company

Competitive Analysis: Leading Companies and New Entrants in the Wire Arc Additive Manufacturing Cell Market
Competitive Analysis: Leading Companies and New Entrants in the Wire Arc Additiv …
The wire arc additive manufacturing cell market is rapidly gaining traction as industries increasingly embrace advanced metal 3D printing technologies. With significant investments and technological breakthroughs, this sector is set to experience remarkable growth, transforming manufacturing processes across multiple fields. Let's explore the market's size, influential players, key trends, and segmentation to understand its future trajectory. Projected Expansion of the Wire Arc Additive Manufacturing Cell Market The wire arc additive manufacturing cell
Future Perspectives: Key Trends Shaping the Viscosupplementation Treatment for Arthritis Market Until 2029
Future Perspectives: Key Trends Shaping the Viscosupplementation Treatment for A …
The viscosupplementation treatment for arthritis market is on the verge of significant expansion, driven by advances in medical technology and a growing demand for effective arthritis therapies. With increasing awareness around early intervention and new treatment options, this sector is poised for rapid development over the coming years. Let's explore the market size, key players, emerging trends, and segment-wise forecasts that define this growing industry. Projected Market Growth and Size of
Segmentation, Major Trends, and Competitive Overview of the Viral Vector Development Service Market
Segmentation, Major Trends, and Competitive Overview of the Viral Vector Develop …
The viral vector development service market is set to experience substantial growth in the coming years, driven by technological progress and increasing demand from various sectors. As gene therapies and advanced treatments gain prominence, the need for efficient viral vector production and development is becoming more critical. Let's explore the market size projections, key players, emerging trends, and the segment structure shaping this industry's future. Projected Expansion and Market Size of
Competitive Landscape: Leading Companies and New Entrants in the Transient Elastography Market
Competitive Landscape: Leading Companies and New Entrants in the Transient Elast …
The transient elastography market is poised for substantial expansion as advancements in healthcare diagnostics continue to evolve. Increasing emphasis on non-invasive techniques and early disease detection is driving widespread adoption, setting the stage for strong market growth in the coming years. Let's explore the current market valuation, leading players, emerging innovations, and key segments shaping this industry. Projected Market Value and Growth of the Transient Elastography Market The transient elastography market is

All 5 Releases


More Releases for Drug

Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming
Global Advanced Drug Delivery Systems Market Size - By Product Type(Oral Drug De …
Market Overview and Report Coverage Advanced Drug Delivery Systems (ADDS) refer to innovative technologies designed to improve the administration and efficacy of therapeutics, enhancing the way medications are delivered to targeted areas within the body. These systems aim to optimize treatment outcomes by increasing the bioavailability, reducing side effects, and facilitating controlled drug release. Employing methods such as nanoparticles, liposomes, and implantable pumps, ADDS are revolutionizing personalized medicine and expanding therapeutic
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Pric …
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, and Clinical Trials Outlook 2029 Report Highlights: * Global Antibody Drug Conjugates Market Opportunity: > 40 Billion By 2029 * Global and Regional Antibody Drug Conjugate Market Insight * Approved Drugs Sales Insight Global and Regional, Yearly and Quarterly, 2019 -2023 * Approved Antibody Drug Conjugates - Availability, Dosage and Price Insight * Insight On Antibody Drug Conjugates In Clinical Trials: > 550
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase